Medullary thyroid cancer.

Current treatment options in oncology

Volumn 1, Issue 4, 2000, Pages 359-367

  Kebebew, E ^a   Clark, O H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CLINICAL TRIAL; HUMAN; MEDULLARY CARCINOMA; PATHOLOGY; PROGNOSIS; RADIATION DOSE; REVIEW; SURVIVAL RATE; THYROID TUMOR; THYROIDECTOMY; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CARCINOMA, MEDULLARY; CLINICAL TRIALS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0034308632     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-000-0052-7     Document Type: Review

References (43)